Top Researchers
Top Medicine Researchers at University of Chicago for 2026
At the University of Chicago, recent medicine research spans a wide range of clinical and translational questions, from blood cancers and lung disease to stroke care, transplantation, and critical care data standards. The breadth of work sampled here shows a community moving across specialties while staying close to patient outcomes and practical decision-making.
Below, you’ll find researchers whose recent publications reflect that mix of focused expertise and collaborative medicine research, with activity clustered around genetics, hematology, pulmonary medicine, oncology, and related public health themes.
Featured Researchers
Anand Patel
Anand Patel’s recent work at the University of Chicago centers on hematology, genetics, and public health questions in TP53-mutant myeloid and lymphoid disease.
Activity over the last year: 48 indexed journal articles.
Top publications:
- Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations (Mar 2025)
- Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults (Aug 2025)
- Heterogeneity in outcomes of TP53‐mutated myeloproliferative neoplasms based on disease phenotype and mutational status (May 2025)
James E. Siegler
James E. Siegler’s University of Chicago publications focus on stroke care, with recent attention to endovascular thrombectomy, carotid stenting, and treatment windows for large vessel occlusion.
Activity over the last year: 44 indexed journal articles.
Top publications:
- Endovascular Thrombectomy for Large Ischemic Core Stroke (Apr 2025)
- Emergent Carotid Stenting During Thrombectomy in Tandem Occlusions Secondary to Dissection: A STOP-CAD Secondary Study (Jan 2025)
- Endovascular Therapy for Patients With Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window (Mar 2025)
Marina Chiara Garassino
Marina Chiara Garassino’s recent University of Chicago work focuses on pulmonary medicine and oncology, especially immunotherapy and long-term outcomes in non-small-cell lung cancer.
Activity over the last year: 42 indexed journal articles.
Top publications:
- Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer—final analysis from the phase II PACIFIC-6 trial (May 2025)
- Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1 (Mar 2025)
- Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis (Oct 2025)
William F. Parker
William F. Parker’s University of Chicago publications span surgery, transplantation, and biomedical engineering, including ICU data standards and heart transplantation outcomes.
Activity over the last year: 31 indexed journal articles.
Top publications:
- A common longitudinal intensive care unit data format (CLIF) for critical illness research (Mar 2025)
- Development of a risk score predicting survival after adult heart transplantation in the United States (Jul 2025)
- Association of the 2018 U.S. Heart Allocation Policy Change and the Survival Benefit of Heart Transplantation (Jun 2025)
Peter A. Riedell
Peter A. Riedell’s recent University of Chicago research emphasizes oncology, pathology, and genetics through CAR-based therapies and follow-up studies in lymphoma.
Activity over the last year: 41 indexed journal articles.
Top publications:
- Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial (Jan 2025)
- Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study (Feb 2025)
- Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma (Feb 2025)
Ayodeji Adegunsoye
Ayodeji Adegunsoye’s University of Chicago work concentrates on pulmonary medicine, pathology, and physiology, with recent publications on interstitial lung disease and idiopathic pulmonary fibrosis.
Activity over the last year: 37 indexed journal articles.
Top publications:
- Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement (Aug 2025)
- Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement (Jun 2025)
- Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation (Apr 2025)
Olatoyosi Odenike
Olatoyosi Odenike’s recent University of Chicago publications center on hematology and genetics, including therapy combinations and molecular characterization in acute myeloid leukemia.
Activity over the last year: 39 indexed journal articles.
Top publications:
- Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML (Jun 2025)
- NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025 (Mar 2025)
- Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial (Apr 2025)
Wendy Stock
Wendy Stock’s University of Chicago research spans hematology, genetics, and public health, with recent work on acute lymphoblastic leukemia, measurable residual disease, and AML treatment.
Activity over the last year: 37 indexed journal articles.
Top publications:
- Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML (Jun 2025)
- Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features (Jun 2025)
- Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts (Jan 2025)
What University of Chicago's Medicine Community Is Working On
Across the featured research, the strongest signals are in genetics, hematology, public health, pulmonary and respiratory medicine, and oncology. Together, these subfields point to an active community working on the molecular drivers of disease, treatment response, and clinical outcomes in cancers, lung disorders, and complex blood diseases. The overlap between genetics and hematology is especially prominent, while pulmonary medicine and oncology reflect sustained attention to respiratory disease and cancer therapy. Public health themes appear alongside these specialties, reinforcing the practical, patient-centered direction of the work.- Genetics - seen across 4 of the featured researchers
- Hematology - seen across 3 of the featured researchers
- Public Health, Environmental and Occupational Health - seen across 3 of the featured researchers
- Pulmonary and Respiratory Medicine - seen across 3 of the featured researchers
- Oncology - seen across 2 of the featured researchers
These recent publications offer a useful snapshot of how medicine research at the University of Chicago is connecting bedside questions with deeper biological and systems-level inquiry. If you’re exploring similar scholarly patterns for your own work, Resub can help streamline citation discovery, manuscript formatting, and submission preparation.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.